The antiphospholipid syndrome and vascular surgery

Vascular

Volumn 6, Issue 1, 1998, Pages 10-16

  Williams, F M K ^a   Hunt, B J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MULTICENTER STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; THROMBOSIS; VASCULAR SURGERY;

EID: 84997941803     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099800600102     Document Type: Review

References (49)

1. Hughes G. R. V., The antiphospholipid syndrome: Ten years on. Lancet, 1993, 342, 341–344.
2. Asherson R. A., Cervera R., “Primary’, “Secondary” and other variants of antiphospholipid syndrome. Lupus, 1994, 3, 293–298.
3. Levine S. R., Brey R. L., Neurological aspects of antiphospholipid antibody syndrome. Lupus, 1996, 5, 347–353.
4. Khamashta M. A., Hughes G. R. V., Antiphospholipid antibodies and antiphospholipid syndrome. Current Opinion in Rheumatology, 1995, 7, 389–394.
5. Beynon H. L. C., Walport M. J., Antiphospholipid antibodies and cardiovascular disease. British Heart Journal, 1992, 67, 281–284.
6. Ordi J., Selva A., Monegal F., Porcel J. M., Martinez-Costa X., Vilardell M., Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis. Journal of Rheumatology, 1993, 20, 1321–1324.
7. Triplett D. A., Assays for detection of antiphospholipid antibodies. Lupus, 1994, 3, 281–287.
8. Blank M., Cohen J., Toder V., Schoenfeld Y., Induction of antiphospholipid syndrome in naïve mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proceedings of the National Academy of Sciences, USA, 1991, 88, 3069–3073.
9. Galli M., Comfurius P., Maassen C., Hemker H. C., De Baets M. H., Van Breda-Variesman P. J. C., Barbui T., Zwaal R. F. A., Bevers E. M., Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet, 1990, 335, 1544–1547.
10. McNeil H. P., Simpson R. J., Chesterman C. N., Krilis S. A., Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proceedings of the National Academy of Sciences, USA, 1990, 87, 4120–4124.
11. Lee N. S., Brewer B. H., Osborne J. C., Beta-2-glycoprotein I: Molecular properties of an unusual apolipoprotein, apolipoprotein H. Journal of Biological Chemistry, 1983, 258, 4765–4770.
12. Steinkasserer A., Barlow P. N., Willis A. C., Kertesz Z., Campbell I. D., Sim R. B., Norman D. G., Activity, disulphide mapping and structural modelling of the fifth domain of human β2-glycoprotein I, FEBS Letters, 1992, 313, 193–197.
13. Matsuura E., Igarashi Y., Yasuda T., Triplett D., Koike T., Anticardiolipin antibodies recognize β2-GPI structure altered by interacting with an oxygen-modified solid phase surface. Journal of Experimental Medicine, 1994, 179, 457–462.
14. Hunt J. E., Simpson R. J., Krilis S. A., Identification of a region of beta-2-glycoprotein I critical for lipid-binding and anticardiolipin cofactor activity. Proceedings of the National Academy of Sciences, USA, 1993, 90, 2141–2145.
15. Kandiah D. A., Hunt J. E., Krilis S. A., Epitope mapping studies of antiphospholipid antibodies and beta 2-GPI using synthetic epitopes. Lupus, 1995, 4 (suppl. 1), S7-S11.
16. Brighton T. A., Hogg P. J., Dai Y.-P., Murray B. H., Chong B. H., Chesterman C. N., Beta2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant. British Journal of Haematology, 1996, 93, 185–194.
17. Roubey R. A. S., Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood, 1994, 84, 2854–2867.
18. Bajaj S. P., Rapaport S. I., Fierer D. S., Herbst K. D., Schwartz D. B., A mechanism for the hypoprothrombinaemia of the acquired hypoprothrombinaemia-lupus anticoagulant syndrome. Blood, 1983, 61, 684–692.
19. Oosting J. D., Derksen R. H. W. M., Bobbink I. W. G., Hackeng T. M., Bouma B. N., De Groot P. G., Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C., or protein S: An explanation for their pathogenic mechanism? Blood, 1993, 81, 2618–2625.
20. Arnout J., The pathogenesis of the antiphospholipid syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 1996, 75(4), 536–541.
21. Galli M., Daldossi M., Barbui T., Antiglycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies. Thrombosis and Haemostasis, 1994, 71, 571–575.
22. Machin S. J., Platelets and antiphospholipid antibodies. Lupus, 1996, 5, 386–387.
23. Vianna J. L., Khamashta M. A., Ordi-Ros J., Font J., Lopez-Soto A., Tolosa C., Franz J., Selva A., Ingelmo M., Vilardell M., Hughes G. R. V., Comparison of the primary and secondary antiphospholipid syndrome: A European multicentre study of 114 patients. American Journal of Medicine, 1994, 36, 3–9.
24. Donaldson M. C., Weinberg D. S., Belkin M., Whittemore A. D., Mannick J. A., Screening for hypercoagulable states in vascular surgical practice: A preliminary study. Journal of Vascular Surgery, 1990, 11, 825–831.
25. Valentine R. J., Kaplan H. S., Green R., Jacobsen D. W., Myers S. I., Clagett G. P., Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective, controlled analysis. Journal of Vascular Surgery, 1996, 23, 53–61.
26. Asherson R. A., Khamashta M., Gil A., Vazquez J., Chan O., Baguley E., Hughes G. R. V., Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. American Journal of Medicine, 1989, 86, 391–399.
27. Herranz M. R., Rivier G., Khamashta M. A., Blaser K. U., Hughes G. R. V., Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 1994, 37, 568–571.
28. Toubi E., Khamashta M. A., Panarro A., Hughes G. R. V., Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. American Journal of Medicine, 1995, 99, 397–401.
29. Bell C. L., Parkington C., Robbins M., Graziano F., Turski P., Kornguth S., Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus: Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis and Rheumatism, 1991, 34(4), 432–441.
30. Scott T. F., Hess D., Brillman J., Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Archives of Internal Medicine, 1994, 154, 917–920.
31. Pelletier S., Landi B., Piette J. C., Ekert P., Coutellier A., Desmoulins C., Fadlallah J. P., Herson S., Valla D., Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. Journal of Hepatology, 1994, 21, 76–80.
32. Piette J. C., Cacoub P., Wechsler B., Renal manifestations of the antiphospholipid syndrome. Seminars in Arthritis and Rheumatism, 1994, 23, 357–366.
33. Barbut D., Borer J. S., Gharavi A., Wallerson D., Devereux R. B., Supino P., Suite N. D. A., Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events. American Journal of Cardiology, 1992, 70, 901–905.
34. Nihoyannopoulos P., Gomez P. M., Joshi J., Loizou S., Walport M. J., Oakley C. M., Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation, 1990, 82(2), 369–375.
35. Khamashta M. A., Cervera R., Asherson R. A., Font J., Gil A., Coltart D. J., Vazquez J. J., Pare C., Ingelmo M., Oliver J., Hughes G. R. V., Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet, 1990, 335, 1541–1544.
36. Roldan C. A., Shively B. K., Lau C. C., Gurule F. T., Smith E. A., Crawford M. H., Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. Journal of the American College of Cardiology, 1992, 20, 1127–1134.
37. Kaplan S. D., Chartash E. K., Pizzarello R. A., Furie R. A., Cardiac manifestations of the antiphospholipid syndrome. American Heart Journal, 1992, 124(5), 1331–1338.
38. Hamsten A., Norberg R., Bjorkholm M., De Faire U., Holm G., Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet, 1986, 1, 113–116.
39. Mattila K., Vaarala O., Palosuo T., Malkamaki M., Valtonen V., Nieminen M., Aho K., Serological response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction. Clinical Immunology and Immunopathology, 1989, 51, 414–418.
40. Morton K. E., Gavaghan T. P., Krilis S. A., Daggard G. E., Baron D. W., Hickie J. B., Chesterman C. N., Coronary artery bypass graft failure — An autoimmune phenomenon?. Lancet, 1986, 2, 1353–1357.
41. Asherson R. A., Higenbottam T. W., Xuan A. T. Dinh, Khamashta M. A., Hughes G. R. V., Pulmonary hypertension in a lupus clinic: Experience with twenty-four patients. Journal of Rheumatology, 1990, 17, 1292–1298.
42. Asherson R. A., Piette J. C., The catastrophic antiphospholipid syndrome 1996: Acute multi-organ failure associated with antiphospholipid antibodies: A review of 31 patients. Lupus, 1996, 5, 414–417.
43. Khamashta M. A., Cuadrado M. J., Mujic F., Taub N. A., Hunt B. J., Hughes G. R. V., The management of thrombosis in the antiphospholipid syndrome. New England Journal of Medicine, 1995, 332, 993–997.
44. Asherson R. A., Chan J. K., Harris E. N., Gharavi A. E., Hughes G. R., Anticardiolipin antibodies, recurrent thrombosis and warfarin withdrawal. Annals of Rheumatic Disease, 1985, 44, 823–825.
45. Rosove M. H., Brewer P. M. C., Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Annals of Internal Medicine, 1992, 117, 303–308.
46. Ginsburg J. S., Wells P. S., Brill-Edwards P., Donovan D., Moffatt K., Johnston M., Stevens P., Hirsh J., Antiphospholipid antibodies and venous thrombosis. Blood, 1995, 86, 3685–3691.
47. Khamashta M. A., Mackworth-Young C., Antiphospholipid (Hughes') syndrome. British Medical Journal, 1997, 314, 244.
48. Lima F., Khamashta M., Buchanan N. M. M., Kerslake S., Hunt B. J., Hughes G. R. V., A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clinical and Experimental Rheumatology, 1996, 14, 131–136.
49. Hunt B. J., Doughty H., Majumdar G., Copplestone A., Kerslake S., Buchanan N., Hughes G., Khamashta M., Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thrombosis and Haemostasis, 1997, 77(1), 39–43.